Vedior NV (“Vedior”), one of the world’s largest recruitment companies, has completed the acquisitions of Delta Pharma and Delta Solutions (together, “Delta”). Delta, a leading clinical trials staffing and IT consulting organization, adds to Vedior North America’s specialty staffing offering and gives them a major presence within the highly competitive Midwest pharmaceutical corridor. The terms of the transaction were not disclosed.
“During the past 18 months, Delta has experienced tremendous growth which is set to continue beyond 2005,” according to Nishen Radia, Managing Director of FocalPoint. “Our goal was to secure full value for this growth even though it was not fully reflected in historical results and to identify the ‘right’ partner for our client. With this transaction, we believe we did just that. This deal represents a perfect example of the increased M&A activity within the specialty staffing arena and a sign of things to come as buyers look to invest in higher margin niche markets.”
“I am excited about the synergies between Vedior and Delta,” states Mike Stomberg, CEO of Delta. “The partnership provides an opportunity to maintain our strong brand recognition and autonomy while leveraging tremendous value by being part of Vedior. The strategic partnership enables us to accelerate our rapid national expansion while maintaining our exceptional history of quality and enhancing our ability to serve our customers.”
FocalPoint is an independent investment bank, specializing in mergers and acquisitions, private placements (both debt and equity), and financial restructurings. The firm’s primary focus is on middle-market companies with revenues between $10 million and $250 million in a diverse range of industries. FocalPoint has an active specialty staffing investment banking practice within both the temporary and permanent staffing sectors.
Please feel free to contact Nishen Radia at (818) 728-6040 with any questions about this transaction.